Prometheus. GA will develop a hand-held, field-portable diagnostic instrument capable of performing nucleic acid-based tests of panels of pathogens associated with febrile illness that will…
Ended Definitive Contract Awarded Last action
- Contract number
- HR001118C0045
- Awardee
-
General Atomics UEI TVRYQ3N3B8H5
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $4,470,383
Award facts
- Opportunity
-
- HR001117S0030 Solicitation number
- Biological Technologies Office (BTO) BAA HR001117S0030 Award Notice · Posted Jan 24, 2018
- Contract value 100% obligated
- $4,470,383.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 32 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $846,660 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $806,436 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $923,029 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $1,133,841 | |
| Funding Only Action | $601,980 | |
| Original award | $158,437 |
Show all 17
About this award
This is a $4,470,383.00 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to General Atomics, a leading defense and technology company headquartered in San Diego, California. The contract, titled "PROMETHEUS", tasks General Atomics with developing a hand-held, field-portable diagnostic instrument capable of performing nucleic acid-based tests for panels of pathogens associated with febrile illness. This diagnostic instrument is being developed to host panel diagnostic tests for pathogens endemic to the Americas and Africa, with the goal of dramatically impacting troop care around the world. The contract does not have a set-aside designation, reflecting General Atomics' status as a large, established defense contractor. The contract has a period of performance ending on March 31, 2023. General Atomics has been awarded a subcontract for crating services related to this contract.
Description
Prometheus. GA will develop a hand-held, field-portable diagnostic instrument capable of performing nucleic acid-based tests of panels of pathogens associated with febrile illness that will dramatically impact troop care around the world. The diagnostic instrument is being developed to host panel diagnostic tests for pathogens endemic to the americas and africa.
Quick answers
Who was awarded contract HR001118C0045?
HR001118C0045 was awarded to General Atomics by Defense Advanced Research Projects Agency (Department of Defense) on January 16, 2018.
How much is contract HR001118C0045 worth?
The government has obligated $4,470,383 on HR001118C0045.
Was contract HR001118C0045 competed?
The extent of competition for HR001118C0045 was full and open competition. The government received 32 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award